Week of April 16, 2024 | Vol. 13, Issue 16

In This Issue

Upcoming Events

Industry Activity

Market Research

M&A Pipeline

Featured Headlines

Recent Transactions

Contact

Xan Smith

Managing Director, Private Equity Coverage & Origination


Jeremy C. Johnson

Senior Managing Director, Head of Investment Banking

About
Research

Industry Snapshot

Upcoming Events

Wells Fargo Championship

May 6-12, 2024 | Quail Hollow Club, Charlotte, NC

124th U.S. Open

June 10-16 | Pinehurst, NC

Let's Meet!

Industry Activity

M&A Transactions

Pharma & Biotech

13 transactions totaling $4,825 million


Supplies, Equipment & Services

12 transactions totaling $800 million


Healthcare Facilities & Distributors

4 transactions totaling $350 million


Healthcare IT & Managed Care

4 transactions totaling $45 million

Featured Chart

Clinical Trial Starts by Disease State

Clinical trials serve as a crucial leading indicator for many pharmaceutical services companies. When segmented by disease state, oncology remains the dominant driver of new clinical trials.

 

Source: ClincialTrials.gov

Trading Comps

Market Research

Bourne Brief

5 Drivers of the PRV Market


Capital Markets Update

2024 Outlook


Bourne Brief

Navigating Tailwinds & Headwinds in Clinical Research Service


Market Insight

Biostorage Services Report


Market Insight

Using Divestitures to Deliver Excess Returns

More Research

M&A Pipeline

Project Ester

Consumer Health - Strategic Partnering | Contact: Robert Stanley

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Trident

Pharma - Buy-Side | Contact: Robert Stanley

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Project Bison

Pharma Support Services - Sell-Side | Contact: Todd Bokus

Acquisition opportunity of a CQV, calibration & metrology, and other pharma support services platform

Project Panther

Pharma Services - Sell-Side | Contact: Jake Curtis

Acquisition opportunity of OTC and personal care CDMO

Project Ignatius

Pharma Services - Sell-Side | Contact: Jake Curtis

Acquisition opportunity of Phase I clinical research site

Project L

Pharma Services - Sell-Side | Contact: Jake Curtis

Acquisition opportunity of a biostatistics and clinical data management platform 

Project Yellowstone

Pharma Services - Sell-Side | Contact: Jake Curtis

Acquisition opportunity of a clinical trial patient technology and services business

Project Nirvana

Pharma - Capital Raise | Contact: Carson Riley

Investment opportunity in sterile injectable pharmaceutical manufacturer and compounder

Featured Headlines

CDMO Kindeva Drug Delivery Installs First Syntegon Versynta microBatch Filling System In North America

Pharmaceutical Online

Thermo Fisher Scientific Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing

Business Wire

Fujifilm to Invest Additional $1.2 Billion to Expand its Large-Scale Cell Culture CDMO Business in North Carolina

Yahoo Finance

CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.

Business Wire

AKB and Axolabs Partner to Build Oligonucleotide cGMP Manufacturing Facility

Contract Pharma

Recent Transactions

Bourne continues to be one of the most active Pharma Services Advisors, having closed 7 transactions with 7 different sponsors within the last 45 days with more to come! Select recent clients and counterparties include:

LinkedIn  Web